This is very interesting. Haven’t read your post
Post# of 157807
(Total Views: 507)
Posted On: 07/08/2025 10:00:14 AM
This is very interesting. Haven’t read your post in awhile thank you for sharing this MGK and taking the time to add imagines in the post.
It explained your own immune system better than your oncologist and easy understand.
Unpacking a legitimate immunological theory connecting:
• CCR5 / RANTES signaling
• leronlimabs persistent role
• Checkpoint inhibition strategy
• Immune cell re-education & memory
• The real risk of stopping treatment too early
You can’t deny the depth of the thought. And if you’re invested in cancer science, Leronlimab, or even the philosophy of how our body fights what’s foreign.
Because one day, you’re going to realize some of the best science wasn’t published in a peer-reviewed journal…
It was posted by someone who cared enough to break it down for free.
It explained your own immune system better than your oncologist and easy understand.
Unpacking a legitimate immunological theory connecting:
• CCR5 / RANTES signaling
• leronlimabs persistent role
• Checkpoint inhibition strategy
• Immune cell re-education & memory
• The real risk of stopping treatment too early
You can’t deny the depth of the thought. And if you’re invested in cancer science, Leronlimab, or even the philosophy of how our body fights what’s foreign.
Because one day, you’re going to realize some of the best science wasn’t published in a peer-reviewed journal…
It was posted by someone who cared enough to break it down for free.
(8)
(0)CytoDyn Inc (CYDY) Stock Research Links
Daniel Rizzo
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
Headquarters: Washington, DC
Mailing & correspondence: 1930 18th St NW Suite B2 PMB 2161, Washington DC 20009
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
Principal Investigator:
FG001|FG002|FG003
https://firegatebiotech.com/2025
FG-001: Integrated Triplet Immunotherapy for Functional HIV Cure
FG-002: Triplet Immunologic Modulation in Oncology — NF-κB / IL-1Ra Axis
FG-003: Neuro-Immune Repair Triplet — Concept and Combination Framework
CCR5 Antagonists & Triplet Immunotherapy Synergy in HIV
HIV Cure Pathways — Functional-Cure Framework Overview
FG-003 Neuro-Immune Repair Triplet — IP & Combination Strategy
— Jeremiah 51:36
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
Headquarters: Washington, DC
Mailing & correspondence: 1930 18th St NW Suite B2 PMB 2161, Washington DC 20009
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
Principal Investigator:
FG001|FG002|FG003
https://firegatebiotech.com/2025
FG-001: Integrated Triplet Immunotherapy for Functional HIV Cure
FG-002: Triplet Immunologic Modulation in Oncology — NF-κB / IL-1Ra Axis
FG-003: Neuro-Immune Repair Triplet — Concept and Combination Framework
CCR5 Antagonists & Triplet Immunotherapy Synergy in HIV
HIV Cure Pathways — Functional-Cure Framework Overview
FG-003 Neuro-Immune Repair Triplet — IP & Combination Strategy
— Jeremiah 51:36